Thyroid medicine recall causes concern

A widespread recall has been issued for one lot of 30mg thyroid tablets from Vitruvias Therapeutics due to potential overdose risks, categorized as a Class I recall by the FDA. The affected product, labeled "Thyroid Tablets, USP," was distributed nationwide and is not the commonly prescribed levothyroxine. Patients taking the medication are advised to consult their healthcare providers, as taking superpotent thyroid medication can cause serious health effects.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل